New-Onset Hyperglycemia in Nondiabetic Chinese Patients Started on Peritoneal Dialysis

American Journal of Kidney Diseases

Volumn 49, Issue 4, 2007, Pages 524-532

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

glucose; patient survival; Renal failure

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PERITONEAL DIALYSIS; PREVALENCE; SURVIVAL RATE; ULTRAFILTRATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE;

EID: 33947311218     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.01.018     Document Type: Article

References (33)

1. Bergstrom J., Furst P., Alvestrand A., and Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44 (1993) 1048-1057
2. Armstrong V.W., Buschmann U., Ebert R., Fuchs C., Rieger J., and Scheler F. Biochemical investigations of CAPD: Plasma levels of trace elements and amino acids and impaired glucose tolerance during the course of treatment. Int J Artif Organs 3 (1980) 237-241
3. Heaton A., Johnston D.G., Burrin J.M., et al. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): The effect of a single dialysis cycle. Clin Sci (Lond) 65 (1983) 539-545
4. Wideroe T.E., Smeby L.C., and Myking O.L. Plasma concentrations and transperitoneal transport of native insulin and C-peptide in patients on continuous ambulatory peritoneal dialysis. Kidney Int 25 (1984) 82-87
5. Armstrong V.W., Creutzfeldt W., Ebert R., Fuchs C., Hilgers R., and Scheler F. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients. Nephron 39 (1985) 141-145
6. Lindholm B., and Karlander S.G. Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis. Acta Med Scand 220 (1986) 477-483
7. Smith W.G., Hanning I., Johnston D.G., and Brown C.B. Pancreatic beta-cell function in CAPD. Nephrol Dial Transplant 3 (1988) 448-452
8. Lameire N., Matthys D., Matthys E., and Beheydt R. Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 30 suppl 1 (1988) S53-S58
9. Kurtz S.B., Wong V.H., Anderson C.F., et al. Continuous ambulatory peritoneal dialysis. Three years' experience at the Mayo Clinic. Mayo Clin Proc 58 (1983) 633-639
10. Lindholm B., and Bergstrom J. Nutritional aspects of CAPD. In: Gokal R. (Ed). Continuous Ambulatory Peritoneal Dialysis (1986), Churchill Livingstone, Edinburgh, Scotland 228-237
11. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
12. Gregg E.W., Cadwell B.L., Cheng Y.J., et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care 27 (2004) 2806-2812
13. Beddhu S., Zeidel M.L., Saul M., et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 112 (2002) 696-701
14. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
15. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome: A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
16. Davies S.J., Phillips L., Naish P.F., and Russell G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12 (2001) 1046-1051
17. Woodward R.S., Schnitzler M.A., Baty J., et al. Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients. Am J Transplant 3 (2003) 590-598
18. Chiu K.C., Cohan P., Lee N.P., and Chuang L.M. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23 (2000) 1353-1358
19. Dickinson S., Colagiuri S., Faramus E., Petocz P., and Brand-Miller J.C. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J Nutr 132 (2002) 2574-2579
20. Ko G.T., Tang J., Chan J.C., et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: An analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 85 (2001) 239-242
21. Szeto C.C., Wong T.Y., Leung C.B., et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58 (2000) 400-407
22. Szeto C.C., Wong T.Y., Chow K.M., Leung C.B., and Li P.K. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study?. Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 18 (2003) 977-982
23. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7 (1996) 198-207
24. Paniagua R., Amato D., Vonesh E., et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 (2002) 1307-1320
25. Wen C.P., Cheng T.Y., Tsai S.P., Hsu H.L., and Wang S.L. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 28 (2005) 2756-2761
26. Deedwania P.C., and Fonseca V.A. Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm. Am J Med 118 (2005) 939-947
27. Mizock B.A. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 98 (1995) 75-84
28. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 17 (2001) 107-124
29. O'Neill P.A., Davies I., Fullerton K.J., and Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22 (1991) 842-847
30. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 99 (1999) 2626-2632
31. Malmberg K., Norhammar A., and Ryden L. Insulin treatment postmyocardial infarction: The DIGAMI Study. Adv Exp Med Biol 498 (2001) 279-284
32. Aljada A., Ghanim H., Mohanty P., Kapur N., and Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87 (2002) 1419-1422
33. Wong T.Y., Szeto C.C., Chow K.M., Leung C.B., Lam C.W., and Li P.K. Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 46 (2005) 713-719